chr1-38915647-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_017821.5(RHBDL2):c.310G>A(p.Gly104Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017821.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHBDL2 | NM_017821.5 | c.310G>A | p.Gly104Ser | missense_variant | Exon 3 of 8 | ENST00000372990.6 | NP_060291.2 | |
RHBDL2 | NM_001304746.2 | c.550G>A | p.Gly184Ser | missense_variant | Exon 3 of 8 | NP_001291675.1 | ||
LOC105378662 | XR_001737994.2 | n.89+2019C>T | intron_variant | Intron 1 of 1 | ||||
LOC105378662 | XR_947215.2 | n.115+380C>T | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.310G>A (p.G104S) alteration is located in exon 3 (coding exon 2) of the RHBDL2 gene. This alteration results from a G to A substitution at nucleotide position 310, causing the glycine (G) at amino acid position 104 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.